# Americas Regional Deep Dive

> *Comprehensive Analysis of North, Central, South America & Caribbean Markets*

---

## Regional Overview

The Americas represent the primary market for Transformational Epicenter expansion, accounting for 12 of the 30 target locations. The region offers unmatched advantages including:

- **Proximity to US UHNW population** (240,000+ individuals with $30M+ assets)
- **Favorable regulatory environments** for plant medicine
- **Established medical tourism infrastructure**
- **Strong hospitality talent pools**
- **Year-round operating climates**

---

## Regional Market Summary

| Subregion | Locations | Primary Offerings | Target Markets |
|-----------|-----------|-------------------|----------------|
| Mexico | 2 | Ibogaine + Full Integration | North America |
| Caribbean | 6 | Psilocybin, Ibogaine, Wellness | US East Coast, UK |
| Central America | 1 | Ayahuasca + Bio-optimization | Americas |
| South America | 3 | Ayahuasca, Traditional Medicine | Global |

---

## Part 1: Mexico - The Foundation Market

### Strategic Importance

Mexico is the cornerstone of the Transformational Epicenter expansion strategy. It offers:

- **Legal clarity**: Ibogaine is unregulated (not on controlled substances list)
- **Medical infrastructure**: JCI-accredited hospitals in key regions
- **US accessibility**: Short flights from all major US cities
- **Operational track record**: 15+ years of ibogaine clinic operations
- **Talent pool**: Bilingual medical and hospitality professionals

### 1.1 Quintana Roo (Primary Flagship)

#### Market Overview

| Factor | Details |
|--------|---------|
| Population | 1.9 million (2025) |
| Annual Visitors | 17.5 million (2024) |
| Medical Tourism | Fastest growing in Mexico |
| UHNW Access | 4 hours from NYC, 3 hours from Miami, 2.5 hours from Dallas |

#### Regulatory Environment

**Ibogaine Status: UNREGULATED**

- Not listed on Mexico's controlled substances schedules
- Equivalent to over-the-counter natural remedy
- 15+ clinics operate openly throughout Mexico
- No enforcement actions against legitimate operations
- COFEPRIS oversight for medical facilities (general, not ibogaine-specific)

**Key Legal Considerations:**
- Medical facility requires COFEPRIS authorization
- Licensed physician must be on staff
- Must comply with applicable NOMs (Official Mexican Standards)
- Foreign physicians must validate credentials through Mexican authorities

#### Medical Infrastructure

**Tier 1 Hospitals (JCI-Accredited):**

| Hospital | Distance from Playa del Carmen | Capabilities | Notes |
|----------|-------------------------------|--------------|-------|
| Galenia Hospital | 45 min (Cancun) | Level 5 (highest in state), full cardiac | Primary partner |
| Hospital Amerimed Cancun | 50 min | JCI since 2018, cardiac cath lab | Backup partner |
| Hospiten Cancun | 50 min | 1,300+ physicians, full imaging | Tertiary option |

**Regional Hospitals:**

| Hospital | Location | Distance | Capabilities |
|----------|----------|----------|--------------|
| Hospital Playa del Carmen | Playa del Carmen | 5-10 min | General emergency, ICU |
| Costamed | Multiple locations | 10-20 min | Network coverage |
| Hospital Joya | Expanding to Tulum | Variable | Growing capacity |

**Medical Workforce:**
- Many physicians trained at Harvard, NYU, American College of Surgeons
- Active FACS, IFSO, ADA, ASPS memberships
- Strong bilingual capability (English/Spanish)
- Nursing certification through Mexican Council of Nursing Certification

#### Real Estate Analysis

**Market Conditions (2025):**

| Metric | Data | Trend |
|--------|------|-------|
| Average Appreciation | 14.68% YoY | ↑ Rising |
| Rent-to-Value Ratio | Highest in Mexico | Favorable |
| Short-term Rental Yield | 8-15% | Strong |
| Purchase Recoup Period | 4-6 years | Attractive |

**Property Pricing:**

| Property Type | Price Range (USD) | Availability |
|---------------|-------------------|--------------|
| 1-BR Condo | $170,000 - $220,000 | High |
| 2-BR Condo | $260,000 - $400,000 | Medium |
| 3-BR Property | $400,000 - $650,000+ | Medium |
| Luxury Villa | $600,000 - $1.5M+ | Available |
| Ultra-Luxury/Beachfront | $1M - $3M+ | Limited |
| Estate (1+ hectare) | $2M - $5M+ | Requires search |

**Recommended Areas:**

| Area | Pros | Cons | Suitability |
|------|------|------|-------------|
| **Playa del Carmen** | Central, hospital access, amenities | Tourist traffic | ✅ Optimal |
| **Puerto Morelos** | Quiet, authentic, 30 min to Cancun hospitals | Smaller community | ✅ Excellent |
| **Akumal** | Tranquil, beautiful cenotes, natural | 45 min to major hospital | ⚠️ Consider |
| **Tulum** | Wellness reputation, spiritual community | Infrastructure issues, airport problems | ❌ Avoid |

#### Safety Assessment

**US State Department: Level 2 (Exercise Increased Caution)**

This is the same advisory level as:
- France
- United Kingdom
- Italy
- Germany

**2025 Security Measures:**
- Operation Summer Vacation 2025: 7,000+ security personnel deployed
- 99.9% of tourist visits occur without incident
- No tourist deaths linked to cartel violence inside hotel zones (2025)
- National Guard, Navy, Army, state/local police coordination

**Risk Factors:**
- Cartel presence exists but not in tourist/residential zones
- Petty crime in tourist areas (manageable with protocols)
- Hurricane season (June-November) - requires contingency planning

#### Competitive Landscape

| Segment | Density | Key Players |
|---------|---------|-------------|
| Ibogaine Clinics | Low | Few in Quintana Roo (most in Baja) |
| Luxury Wellness | Medium | Chablé, Rosewood, upcoming openings |
| Medical Tourism | Medium | Bariatric, dental, cosmetic focused |
| Bio-optimization | Low | White space opportunity |

**Competitive Advantage:** First integrated four-pillar facility in Quintana Roo.

#### Implementation Recommendation

**Site Selection Criteria:**
1. Within 30 minutes of JCI hospital
2. 0.5-1 hectare minimum
3. Privacy from public areas
4. Natural setting (cenote access, jungle, or beach)
5. Residential or mixed-use zoning
6. Expansion potential

**Priority Actions:**
1. Engage local real estate advisor with hospitality/medical experience
2. Identify 5-7 candidate properties for site visits
3. Commission legal opinion from COFEPRIS-experienced counsel
4. Begin hospital partnership discussions (Galenia primary)

---

### 1.2 Baja California (Secondary Market)

#### Market Overview

| Factor | Details |
|--------|---------|
| Population | 3.8 million (Baja California state) |
| Key Benefit | 20 minutes from San Diego |
| Ibogaine History | 10+ years, longest-running clinics |
| Target Market | US West Coast |

#### Regulatory Environment

**Status: UNREGULATED** (Same as Quintana Roo)

Key difference: Established track record with 6+ operating ibogaine clinics.

#### Medical Infrastructure

**Primary Hospitals:**

| Hospital | Location | Distance from Rosarito | Notes |
|----------|----------|------------------------|-------|
| Hospital General Tijuana | Tijuana | 20-30 min | General medical center |
| Hospital Angeles Tijuana | Tijuana | 25-35 min | Private, higher quality |
| UCSD Medical Center | San Diego, USA | 40-60 min | Emergency evacuation option |

**Cross-Border Consideration:**
- San Diego hospitals accessible for extreme emergencies
- Requires pre-arranged evacuation protocols
- Additional insurance considerations for US-Mexico transfer

#### Safety Assessment

**US State Department: Level 3 (Reconsider Travel)**

However, important distinctions:
- Advisory applies primarily to border zone (Tijuana)
- Coastal tourist areas (Rosarito, Ensenada) have lower risk
- Violence is concentrated in specific areas, not tourist zones
- UK FCO advises caution but not against all travel

**Mitigation Strategies:**
1. Locate in gated communities (Rosarito Beach)
2. Avoid immediate border zone
3. Client education on actual vs. perceived risk
4. Enhanced security protocols

#### Existing Clinic Models

| Clinic | Features | Learning Opportunities |
|--------|----------|------------------------|
| Baja Ibogaine Center | 4,500 sq ft, tennis, pool, private beach | Family-oriented approach |
| Casa Santa Isabel | Only fully licensed clinic, on-site pharmacy/lab | Medical legitimacy model |
| Experience Ibogaine | Longest-running, established reputation | Track record validation |
| Anzelmo Ibogaine | Beachfront, gated community | Location model |

#### Real Estate Analysis

| Property Type | Price Range (USD) | Comparison to Q. Roo |
|---------------|-------------------|---------------------|
| Residential | $137,000 avg | 60% lower |
| Commercial/Clinic | $200K - $800K | 50% lower |
| Beachfront Luxury | $500K - $2M | 40% lower |

**Advantage:** Significant cost savings for comparable properties.

#### Implementation Recommendation

**Best Use Case:**
- Serve US West Coast market
- Clients prioritizing US proximity
- More price-sensitive operations
- Partnership or management contract with existing clinic

**Priority Actions:**
1. Due diligence on existing clinic partnership opportunities
2. Evaluate Rosarito Beach gated communities
3. Develop client education materials addressing Level 3 advisory
4. Establish San Diego evacuation protocols

---

## Part 2: Caribbean Markets

### Regional Overview

The Caribbean offers unique advantages:
- Legal psilocybin (Jamaica, Bahamas, St. Vincent)
- US East Coast accessibility
- English-speaking markets
- Established luxury tourism
- Year-round tropical climate

### 2.1 Jamaica (Montego Bay)

#### Regulatory Environment

**Psilocybin Status: FULLY LEGAL**

This is not a grey area or decriminalization—psilocybin is explicitly LEGAL:
- Never prohibited under Dangerous Drugs Act
- Possession, sale, cultivation all legal
- Government actively promoting psychedelic industry
- JAMPRO encouraging research and development

**Government Position (2025):**
"Jamaica is positioning itself as the primary destination for psychedelic research and development."

#### Medical Infrastructure

**Primary Hospitals:**

| Hospital | Location | Capabilities | Distance from Montego Bay |
|----------|----------|--------------|---------------------------|
| Cornwall Regional Hospital | Montego Bay | General medicine, ICU | 15-20 min |
| University Hospital of the West Indies | Kingston | Tertiary care | 2.5 hours |
| Private clinics | Various | Basic emergency | 10-15 min |

**Limitations:**
- No JCI-accredited hospitals
- Cardiac capability limited compared to Mexico
- Requires enhanced on-site medical capability

**Mitigation:**
- Medical director with hospital privileges
- On-site cardiac monitoring equipment
- Air evacuation contract to Miami

#### Existing Market Validation

| Center | Location | Pricing | Model Validation |
|--------|----------|---------|------------------|
| Atman Retreat | Montego Bay | Premium | Historic property, hospital partnership, NYU advisors |
| ONE Retreats | Negril | $4,500/7 days | Mid-market viable |
| Evolution Retreats | Negril | Premium | Ultra-luxury at Tensing Pen (highest-rated resort) |
| Mycelia | Near Montego Bay | $3,995+ | All-inclusive, lab-tested |

**Key Learnings:**
- Premium pricing sustainable in Jamaica market
- Hospital partnerships are achievable
- US-trained advisors add credibility
- Ultra-luxury positioning validated

#### Real Estate Analysis

| Property Type | Price Range (USD) | Notes |
|---------------|-------------------|-------|
| Boutique resort | $1M - $5M | Several available |
| Beachfront estate | $2M - $8M | Limited inventory |
| Development land | $500K - $2M | Good availability |

**Recommended Areas:**
- Montego Bay corridor (hospital access)
- Ocho Rios (upscale, central)
- Port Antonio (exclusive, natural)

#### Implementation Recommendation

**Positioning:** Psilocybin-focused programs with luxury wellness integration.

**Differentiation from Jamaica Competitors:**
- Medical rigor (physician-supervised)
- Luxury hospitality standards
- Pre-care and integration ecosystem
- Bio-optimization integration

---

### 2.2 The Bahamas (Nassau/Exumas)

#### Unique Value Proposition

**Only Caribbean location where BOTH psilocybin AND ibogaine are accessible.**

This allows combined treatment protocols unavailable elsewhere in the region.

#### Regulatory Environment

| Substance | Status | Notes |
|-----------|--------|-------|
| Psilocybin | Legal | Not on Dangerous Drugs list |
| Ibogaine | Accessible | Reportedly available at resorts |
| 5-MeO-DMT | Accessible | Available at treatment centers |

**Emerging Framework:**
- TREAT Special Economic Zone under development
- Could formalize psychedelic wellness industry

#### Existing Market Validation

| Center | Services | Validation |
|--------|----------|------------|
| Avante Institute | Ibogaine, psychedelic therapy | 10+ years, addiction/depression/PTSD |
| Oceanside Treatment Center | Ibogaine + Psilocybin | Combined protocols proven |
| Psilocybin Therapy Bahamas | Psilocybin | Multi-day retreat model |

#### Implementation Recommendation

**Positioning:** Combined ibogaine + psilocybin protocols for US East Coast market.

**Location Focus:**
- Nassau for medical infrastructure access
- Exumas for ultra-luxury positioning

**Key Advantages:**
- Short flights from Florida
- English-speaking
- Financial services infrastructure (UHNW familiar)
- Dual-modality offering

---

### 2.3 Other Caribbean Markets

#### St. Vincent & Grenadines

| Factor | Assessment |
|--------|------------|
| Regulatory | Psilocybin accessible |
| Medical | Limited - requires enhanced on-site |
| Positioning | Ultra-exclusive, pristine |
| Investment | $15-20M for satellite facility |

#### Cayman Islands

| Factor | Assessment |
|--------|------------|
| Regulatory | Medical wellness focus (no plant medicine clarity) |
| Medical | Good private healthcare |
| Positioning | Tax-efficient, financial industry clientele |
| Investment | $25-30M premium market |

#### Trinidad & Tobago

| Factor | Assessment |
|--------|------------|
| Regulatory | Emerging ibogaine interest |
| Medical | Adequate infrastructure |
| Positioning | South American oil wealth proximity |
| Investment | $12-18M early-mover opportunity |

#### Turks & Caicos

| Factor | Assessment |
|--------|------------|
| Regulatory | Wellness focus only |
| Medical | Limited |
| Positioning | Ultra-luxury US East Coast |
| Investment | $20-25M satellite |

#### Antigua

| Factor | Assessment |
|--------|------------|
| Regulatory | Wellness focus only |
| Medical | Basic |
| Positioning | Caribbean hub, established luxury |
| Investment | $15-20M satellite |

---

## Part 3: Central America

### 3.1 Costa Rica (Guanacaste)

#### Regulatory Environment

**Status: LEGAL GREY AREA**

| Substance | Status | Risk Level |
|-----------|--------|------------|
| Ayahuasca | Unscheduled but DMT controlled | Medium |
| Psilocybin | Listed as controlled (2020) but lax enforcement | High |
| Ibogaine | Not specifically addressed | High - NOT RECOMMENDED |

**Critical Warning:**
- DMT is controlled under Law #8204
- Commercial ayahuasca use can result in 8-15 years imprisonment
- Of ~80 plant medicine centers, only 3 have licenses
- At least 2 psychedelic-related deaths in past 18 months

#### The Rythmia Model

Rythmia Life Advancement Center demonstrates the licensed pathway:

| Aspect | Details |
|--------|---------|
| Licensing | Costa Rica Ministry of Health + IAFA + Municipal |
| Claim | "Only medically licensed facility in the world to offer Ayahuasca" |
| Plants | Banisteriopsis Caapi, Una De Gato, Mimosa Tenuiflora, Nicotiana Rustica |
| Medical | Chief Medical Officer, licensed physicians and nurses |
| Model | All-inclusive luxury medical facility |

**Key Learning:** Licensing IS possible with proper legal navigation and plant selection.

#### Medical Infrastructure

**San Jose (Best in Country):**

| Hospital | Capabilities | Notes |
|----------|--------------|-------|
| Hospital CIMA | JCI-accredited, US VA accredited, 170+ physicians | Primary option |
| Clinica Biblica | Largest private, $50M infrastructure | Strong backup |
| Clinica Catolica | High-quality private | Alternative |

**Guanacaste Challenge:**
- 2+ hours from JCI hospitals (San Jose)
- Liberia has basic emergency services only
- Requires enhanced on-site capability or air evacuation

#### Blue Zone Positioning

Nicoya Peninsula is a certified Blue Zone (one of 5 worldwide):
- Highest longevity population in the Americas
- Research hub for longevity science
- Unique positioning for bio-optimization + longevity programs

#### Real Estate Analysis

| Location | Price/m² (USD) | Notes |
|----------|----------------|-------|
| Tamarindo | $966 - $6,302 | Tourist hub |
| Nosara | $1,641 - $4,690 | Yoga/wellness hub |
| Nicoya Peninsula | $800 - $3,000 | Blue Zone, authentic |
| Guanacaste average | $1,000 - $3,500 | Good value |

**Appreciation:** Up to 400% in 3 years in some Guanacaste areas.

#### Implementation Recommendation

**Positioning:** Ayahuasca-focused (following Rythmia model) + Bio-optimization + Blue Zone longevity.

**NOT RECOMMENDED for ibogaine** due to legal uncertainty.

**Priority Actions:**
1. Engage Ministry of Health licensing counsel
2. Evaluate Rythmia model replicability
3. Identify Nicoya Peninsula properties
4. Develop Blue Zone longevity programming

---

## Part 4: South America

### 4.1 Peru (Sacred Valley)

#### Unique Value Proposition

**Authentic ayahuasca tradition with legal protection.**

#### Regulatory Environment

| Substance | Status | Notes |
|-----------|--------|-------|
| Ayahuasca | Legal | Protected for traditional use |
| Traditional Healers | Recognized | Curandero/shaman legal status |

Peru declared ayahuasca part of national cultural heritage in 2008.

#### Challenges

| Challenge | Mitigation |
|-----------|------------|
| Remote locations | Partner with established centers |
| Medical infrastructure gaps | Enhanced on-site + air evacuation |
| Cultural sensitivity | Indigenous partnership model |
| Supply chain | Local sourcing, backup systems |

#### Implementation Recommendation

**Model:** Partnership with established centers rather than building new facility.

**Best Centers for Partnership:**

| Center | Location | Model |
|--------|----------|-------|
| Temple of the Way of Light | Iquitos | Medical screening, research partnerships |
| Arkana | Sacred Valley | Luxury positioning |
| Soltara | Peru operations | Western-medical integration |

---

### 4.2 Brazil (Bahia)

#### Regulatory Environment

**Ayahuasca is LEGAL** for religious/spiritual use (Santo Daime, União do Vegetal traditions).

| Status | Details |
|--------|---------|
| Religious Use | Fully legal since 2010 |
| Therapeutic Use | Grey area, evolving |
| Research | Active studies |

#### Market Opportunity

- South American UHNW market (25,000+ individuals)
- São Paulo, Rio de Janeiro feeder markets
- Growing wellness tourism infrastructure

#### Implementation Recommendation

**Positioning:** Ayahuasca + wellness for South American and global markets.

**Location Focus:** Bahia coast (Trancoso, Itacaré) for luxury positioning.

---

### 4.3 Canada (British Columbia)

#### Regulatory Environment

**Status: REGULATED ACCESS EMERGING**

| Pathway | Status | Notes |
|---------|--------|-------|
| Section 56 Exemptions | Active | Psilocybin for end-of-life |
| Special Access Program | Active | Therapist access pathway |
| Clinical Trials | Active | Multiple studies underway |
| Decriminalization | Some cities | Vancouver not prosecuting |

#### Implementation Recommendation

**Timeline:** Phase 4 (Years 7-10) pending regulatory evolution.

**Positioning:** Regulated psilocybin-assisted therapy as framework develops.

**Location Focus:** British Columbia (Vancouver Island, Whistler area).

---

## Americas Summary Matrix

| Location | Regulatory | Medical | Access | Real Estate | Talent | Climate | Cost | TOTAL |
|----------|------------|---------|--------|-------------|--------|---------|------|-------|
| Quintana Roo, MX | 23 | 19 | 15 | 13 | 10 | 9 | 5 | **94** |
| Baja California, MX | 23 | 16 | 14 | 13 | 9 | 7 | 5 | **87** |
| Jamaica | 22 | 14 | 14 | 13 | 8 | 9 | 5 | **85** |
| Bahamas | 21 | 14 | 14 | 11 | 8 | 9 | 7 | **84** |
| Costa Rica | 17 | 16 | 13 | 12 | 9 | 10 | 6 | **83** |
| St. Vincent | 18 | 12 | 12 | 13 | 8 | 10 | 6 | **79** |
| Cayman Islands | 14 | 15 | 14 | 10 | 9 | 10 | 6 | **78** |
| Canada (BC) | 16 | 18 | 13 | 10 | 10 | 7 | 4 | **78** |
| Peru | 19 | 10 | 11 | 13 | 8 | 9 | 7 | **77** |
| Turks & Caicos | 13 | 12 | 14 | 11 | 8 | 10 | 8 | **76** |
| Brazil | 17 | 14 | 12 | 12 | 8 | 8 | 4 | **75** |
| Antigua | 12 | 12 | 13 | 12 | 8 | 10 | 7 | **74** |
| Trinidad & Tobago | 15 | 13 | 11 | 12 | 8 | 9 | 5 | **73** |

---

## Strategic Recommendations for Americas

### Phase 1 Priority (Years 1-3)

1. **Quintana Roo, Mexico**: Flagship launch - all four pillars
2. **Baja California, Mexico**: US West Coast hub - ibogaine focus
3. **Jamaica**: Psilocybin center - legal clarity advantage
4. **Costa Rica**: Ayahuasca + Blue Zone longevity

### Phase 2 Expansion (Years 3-5)

1. **Bahamas**: Combined ibogaine + psilocybin - US East Coast
2. **St. Vincent & Grenadines**: Ultra-exclusive satellite
3. **Peru**: Partnership model - authentic ayahuasca

### Long-Term (Years 5-10)

1. **Canada**: As regulatory framework matures
2. **Caribbean satellites**: Turks & Caicos, Antigua, Caymans
3. **Brazil**: South American hub development

---

*Document Version: 1.0*
*Last Updated: January 2026*
*Classification: Strategic / Confidential*
